Manufacturing Partner Manufacturing Partner

Global Footprint

Manufacturing plants and a strong network of business partners and marketing offices strategically located around the world.

Excellence in manufacturing

Manufacturing Capabilities

Strategically located advanced manufacturing facilities around the world, including India, the US, China, Russia, Egypt, Mexico and Indonesia. Approved by strict global regulatory authorities.Facilities have integrated quality systems and processes to ensure compliance with GMP (good manufacturing practices). They are also vertically integrated and can be used for large-scale production of APIs, formulations in various dosage forms quickly.

We make ongoing investments in upgrading manufacturing facilities, with a particular emphasis on deploying advanced machinery and adopting the latest technologies to comply with 21 CFR. In addition to allowing us to consistently produce high-quality medicines at an affordable cost, it helps us pass regulatory audits with relative ease. These advantages make us the strategic partner of choice for the world's leading pharmaceutical companies.

WE HAVE APPROVALS FROM MULTIPLE MINISTRIES OF HEALTH AND GLOBAL REGULATORY AUTHORITIES INCLUDING:

Annual Production Capacity

APIS

reactor volume 1.94 million gallons

Installed capacity36,878 million tons

Formulations

tablets

45 billion units
capsules

6.7 billion units
liquids

20 million units
granules

360 tons
Injectables

181 million units